Psychologists in West Sacramento, CA Accepting Medicare
5 Psychologists found. Showing 1 - 5
 Sunita Chamber Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 500 Jefferson Blvd # B, West Sacramento, CA 95605 Phone: 916-375-6350 Fax: 916-375-6355 |
Dr. Erika Annell Frieze, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1550 Harbor Blvd Ste 206, West Sacramento, CA 95691 Phone: 530-302-5791 |
 Dr. Joseph Jerry Armendarez, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1550 Harbor Blvd Ste 200, West Sacramento, CA 95691 Phone: 530-302-5791 |
Macey M Espinoza Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3120 Freeboard Dr Ste 102, West Sacramento, CA 95691 Phone: 530-351-7975 |
Mrs. Beverley Elizabeth Calderone, M.A Psychologist Medicare: Not Enrolled in Medicare Practice Location: 500-b Jefferson Boulevard, Suite 150, West Sacramento, CA 95605 Phone: 916-375-6350 |
News Archive
K-V successfully completes FDA inspection for resumption of manufacturing and shipment of products
K-V Pharmaceutical Company announced today that it has received notice from the U.S. Food and Drug Administration ("FDA") of the successful completion of an inspection of the Company's facilities and approval to return its first product to market. Under the Company's Consent Decree, successful FDA inspections of the Company's quality systems, processes and facilities are expected to be required before K-V is permitted to resume manufacturing and shipment of particular products.
Hypermethylation serves as protective barrier inhibiting development of ALS, FTD
Penn Medicine researchers have discovered that hypermethylation - the epigenetic ability to turn down or turn off a bad gene implicated in 10 to 30 percent of patients with Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Degeneration (FTD) - serves as a protective barrier inhibiting the development of these diseases.
IMRIS sells IMRISNV to Connecticut-based Yale-New Haven Hospital
IMRIS Inc. ("IMRIS" or the "Company") today announced the sale of IMRISNV to Connecticut-based Yale-New Haven Hospital (the "Hospital"), the primary teaching hospital for the Yale School of Medicine.
Investigational drug reduced triglycerides in patients with severe hypertriglyceridemia, acute pancreatitis
The investigational drug evinacumab reduced triglycerides in patients with severe hypertriglyceridemia (sHTG) and a history of hospitalizations for acute pancreatitis in a phase 2 global study led by Mount Sinai.
Young women who smoke significantly increase their risk of a stroke
New research from scientists in the U.S. has found that the risk of younger women having a stroke is double if they smoke and if they are heavy smokers they have nine times the stroke risk.
› Verified 5 days ago
Counselors
Pharmacists
Dentists
Clinical Social Workers
Psychologists
Occupational Therapists